Thrasos Innovation raises $21 mln
Thrasos Innovation has raised a $21 million financing round from investors including the Fonds de solidarité FTQ, BDC Venture Capital and SR One. Thrasos, of Montreal, is biotech focused on developing therapies to treat kidney disease.
1 April 2015•2 mins read
